Helmut
★★★
avatar
Homepage
Vienna, Austria,
2005-08-16 13:03
(edited by HS on 2007-08-24 14:22)

Posting: # 22
Views: 12,232
 

 Updated Canadian Guidelines [Regulatives / Guidelines]

Dear all!

Canada's HPFB published a new set of Documents:
  • 12 May 2004, DRAFT GUIDANCE FOR INDUSTRY
    Preparation of Comparative Bioavailability Information for Drug Submissions in the CTD Format (91kB PDF)
  • 28 May 2004, DRAFT GUIDANCE FOR INDUSTRY
    Use of Metabolite Data in Comparative Bioavailability Studies (27kB PDF)
  • 03 June 2005, NOTICE TO INDUSTRY
    Bioequivalence Requirements for Combination Drug Products (12kB PDF)
  • 08 June 2004, GUIDANCE FOR INDUSTRY
    Bioequivalence Requirements: Comparative Bioavailability Studies Conducted in the Fed State (25kB PDF)
  • 22 June 2005, NOTICE TO INDUSTRY
    Bioequivalence Requirements for Long Half-life Drugs (13kB PDF)
  • 22 June 2005, NOTICE TO INDUSTRY
    Bioequivalence Requirements for Drugs for Which an Early Time of Onset or Rapid Rate of Absorption Is Important (rapid onset drugs)
    (15kB PDF)
  • 31 May 2006, GUIDANCE FOR INDUSTRY
    Bioequivalence Requirements: Critical Dose Drugs (38kB PDF)
HTML-Versions of all Documents

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes
Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
19,810 posts in 4,198 threads, 1,360 registered users;
online 6 (1 registered, 5 guests [including 4 identified bots]).
Forum time (Europe/Vienna): 07:20 CEST

A big computer, a complex algorithm and a long time
does not equal science.    Robert Gentleman

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5